| FDA sees promise in new total artificial heart technology, granting it ‘breakthrough’ status () |
| New-look peripheral stent with expandable spikes receives FDA’s de novo classification () |
| The lack of diversity in cardiac surgery trials may be harmful to patients () |
| SCAI celebrates legacies of pioneer pediatric cardiologists () |
| Private equity's influence continues to rise in cardiology—what does that mean for patient care? () |
| Terumo Interventional Systems launches dual-layer micromesh carotid stent after FDA approval () |
| How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR () |
| Marijuana use linked to blood vessel damage—impact seen with smoking and edibles () |
| Cuffless blood pressure measurement devices: Convenient, but not ready for clinical use () |
| Veteran surgeon unpacks major changes in the world of cardiac surgery () |
| Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval () |
| The average wait time to see a cardiologist is now more than a month () |
| FDA approves self-expanding Tendyne TMVR device from Abbott () |
| Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival () |
| Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards () |
| Medtronic drug-coated balloon gains multiple new approvals () |
| SCAI wants lead-free cath labs and a better work-life balance for cardiologists () |
| Cardiologist shares positive first-in-human data on TriCares TTVR device () |
| FDA wants new heart damage warnings added to COVID-19 vaccines () |
| Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs () |
| Work begins on first ATTR-CM study of its kind () |
| Cardiologists make history, use new robotic imaging system for first time () |
| Medtronic to spin off its diabetes business () |
| LVOT modification during robotic mitral valve repair limits complications () |
| Stroke care continues to evolve thanks to AI, cardiologists and more () |
| Johnson & Johnson MedTech launches new 2D ICE catheter () |
| Medtronic gains a key approval for Evolut TAVR valves () |
| Chest tube-clearing device improves recovery, limits readmissions after heart surgery () |
| IVL delivers significant value for women, real-world data confirm () |
| Same-day discharge after TAVR linked to positive outcomes () |
| Johnson & Johnson MedTech ordered to pay $147M for antitrust violations () |
| 2 out of 5 heart failure patients are not seeing a cardiologist () |
| Heart patients, stroke survivors may live longer if they stay active after hospital discharge () |
| Robotic PCI confirmed to be both safe and effective in new comprehensive analysis () |
| Cardiology employment models undergoing a dramatic shift () |
| AI delivers real-time blood clot monitoring, helping cardiologists make treatment decisions () |
| Original Banksy artwork headed to auction—proceeds will help fund heart research () |
| Duke specialists to detail the benefits of treating heart failure with Barostim () |
| Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes () |
| TAVR for Today’s Patient: Updates on Data, Risk, Anatomy, and Access () |
| Imaging for chest pain: CT- and ICA-first strategies linked to similar long-term health status () |
| Abbott's FreeStyle Libre helps patients with diabetes stay out of the hospital () |
| Semaglutide works fast, protecting the heart before weight loss kicks in () |
| It may not be easy, but it changes lives: Reframing myths of healthcare leadership () |
| PCI just as successful when patients have a history of TAVR—but there are some added risks () |
| Cardiology groups among the many voices asking Congress not to cut Medicaid () |
| FDA approves popular ultrasound enhancing agent for pediatric patients () |
| Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve () |
| FDA gives AI-powered blood test for obstructive CAD breakthrough device designation () |
| New drug for obstructive HCM outperforms the current standard of care () |
| GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind () |
| When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR () |
| ASNC, ACC ask US government not to tariff radiopharmaceuticals () |
| Gastric bypass surgery linked to lower heart attack risk than gastric sleeve () |
| Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients () |
| TAVR and SAVR deliver similar outcomes for patients with low-flow, low-gradient aortic stenosis () |
| A new use for IVL: helping cardiologists secure transcarotid access for TAVR () |
| Cardiologists are first in world to use new cooling device to terminate AFib during surgery () |
| CCTA shows colchicine's impact on atherosclerosis progression () |
| Rates of obesity, high blood pressure and diabetes keep climbing in US () |
| AI-enabled CCTA evaluations reduce use of invasive imaging exams () |
| High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help () |
| Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients () |
| Stenting ‘an important treatment option’ for PCI patients with complete blockages () |
| Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients () |
| World’s first leadless LBBAP procedures linked to ‘promising’ outcomes () |
| Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure () |
| AI predicts LBBB risk in TAVR patients prior to treatment () |
| New SCAI president lists advocacy, cardiogenic shock among his top priorities () |
| Consistent cannabis use linked to multiple cardiovascular risks for heart failure patients () |
| A super alternative: BATMAN helps cardiologists limit complications during TMVR () |
| ‘A defining moment’: How cardiologists can get the most out of CT-guided PCI () |
| Nonprofit group helps doctors and startups bring new cardiovascular tech to market () |
| FDA approves new AI-enabled wearable cardioverter defibrillator () |
| Cardiologists share late-breaking TAVR data on first day of SCAI 2025 () |
| Latest EARLY TAVR data suggest it is time to update industry guidelines () |
| A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis () |
